 Lung cancer,30
 lung cancer,23
 NSCLC,22
 non-small cell lung cancer,15
 Non-small cell lung cancer,14
Apoptosis,12
 proliferation,11
 metastasis,8
 Proliferation,8
 Lung adenocarcinoma,8
 Immunotherapy,8
Cancer,7
 Metastasis,7
 lung adenocarcinoma,7
 prognosis,7
 Non-small-cell lung cancer,6
 PD-L1,6
 Apoptosis,6
 cancer,6
 Prognosis,5
Lung cancer,5
 breast cancer,5
 immunotherapy,5
 invasion,5
Breast cancer,5
 Epidemiology,4
 Tumor microenvironment,4
NSCLC,4
 Chemotherapy,4
 non-small-cell lung cancer,4
cancer,4
 lung neoplasms,4
 Stereotactic body radiation therapy,4
EMT,3
 diagnosis,3
 extracellular vesicles,3
 epidemiology,3
 apoptosis,3
 Gastric cancer,3
 Cisplatin,3
 Migration,3
 Prostate cancer,3
 Autophagy,3
 Osimertinib,3
 Risk factors,3
 radiotherapy,3
 β-catenin,3
 Epidermal growth factor receptor,3
lung cancer,3
 ROS,3
 Brain metastasis,3
Afatinib,3
 inflammation,3
 Invasion,3
 Melanoma,3
 Computed tomography,3
 Molecular docking,3
 survival,3
 Colorectal cancer,3
 Cytotoxicity,3
 Pulmonary fibrosis,2
 Exosomes,2
 Immune checkpoint inhibitor,2
 p53,2
 Erlotinib,2
 PVT1,2
 Glioma,2
 Nrf2,2
 Small cell lung cancer,2
 oxidative stress,2
EGFR,2
 Mortality,2
 Salvage,2
 gefitinib resistance,2
 Non-Small Cell Lung Cancer,2
 SBRT,2
 migration,2
 Pulmonary nodule,2
 malignant pleural effusion,2
 Incidence,2
 Alectinib,2
 Serum biomarker,2
 Radiotherapy,2
 Radon,2
 sepsis,2
 Respiratory diseases,2
 Cell death,2
 targeted therapy,2
 drug delivery,2
 VATS,2
PD-1,2
 Surgery,2
 Gefitinib,2
 Hydrogen,2
Drug resistance,2
 Cell cycle arrest,2
 SOX2,2
 interstitial lung disease,2
 Gene delivery,2
 Radiomics,2
 colorectal cancer,2
 triple-negative breast cancer,2
 immune checkpoint inhibitors,2
 Mesothelioma,2
PET,2
apoptosis,2
Arsenic,2
Chemoresistance,2
 Obesity,2
 Outcome,2
 surgery,2
 imaging,2
 TMB,2
Biomarker,2
 palliative care,2
 pharmacokinetics,2
AMPK,2
 Metastatic breast cancer,2
 Overall survival,2
 platinum-based chemotherapy,2
 Toxicity,2
 Crizotinib,2
KRAS,2
 innate immunity,2
 metastatic,2
 autophagy,2
Adenocarcinoma,2
Chemotherapy,2
 prostate cancer,2
Immunotherapy,2
Anticancer,2
 Survival,2
 Next-generation sequencing,2
 Cell proliferation,2
 Cytotoxic activity,2
 esophageal cancer,2
 lung,2
 Pembrolizumab,2
 chemotherapy,2
 Corticosteroids,2
 EMT,2
 Silver nanoparticles,2
biomarker,2
 Lung metastasis,2
 MET,2
 SEER-Medicare,2
 EGFR,2
 biomarkers,2
 Point-of-care diagnostics,1
 poly ,1
 Forkhead box P3,1
 protein degradation,1
 vascular,1
Biobank,1
 circRNAs,1
 benzimidazo[1,1
Kank1,1
#NAME?,1
 Charge-convertible nanocarriers,1
 Pulmonary Metastasis,1
Amide-sulfamide derivatives,1
 flow cytometry,1
 fosaprepitant,1
 Respiratory function tests,1
 Circulating biomarkers,1
 Living-cell device,1
 Stroke,1
 Lipocalins,1
 Extracellular vesicles,1
Gd2O3-doped carbon-11-choline-lenvatinib nanoparticles contrast-positron emission tomography-computed tomography,1
 human,1
 Multi-targeted inhibitor,1
 VATs,1
 single-cell analysis,1
 Cost-effectiveness analysis,1
 oxidative phosphorylation,1
 EGFR-TKI,1
 Oesophageal squamous cell carcinoma,1
 organ dysfunction,1
Compensatory lung growth,1
 nonsmall cell lung cancer ,1
E-cadherin,1
 endothelial cells,1
 Surveillance,1
cardiomyocyte apoptosis,1
 immune-relate adverse events,1
 Dementia,1
 Migration and invasion,1
SOX6,1
Cisplatin,1
 practice patterns,1
 HTX-019,1
Colorectal Cancer,1
H2O2,1
 Spatial cross-validation,1
Genetically-engineered mouse models,1
 qualitative research,1
asbestosis,1
 Chromobox 4,1
Anti-CTLA-4,1
 Proteins,1
 Metal–organic frameworks,1
 lungs,1
 p21CIPI,1
 Smartphone-based detection,1
 long non-coding RNA,1
 Cumulative antibiotics,1
 human lung adenocarcinoma,1
 BRG1,1
 hsa-circ-0000211,1
 immune checkpoint inhibitor,1
 TNFSF4,1
 dynamic simulation,1
 Inhibitors,1
Epithelial-mesenchymal transition,1
 cellular uptake,1
 Biomarkers,1
 HCV,1
 Social support,1
 Maxillofacial,1
 Immunodiagnosis,1
 Therapeutic strategy,1
 Treatment,1
 Dietary energy intake,1
Endoscopy,1
 Patient monitoring,1
Autoimmune,1
 Germline mutation,1
 invasion and metastasis,1
 Interleukin-17A,1
 Dry-column flash chromatography,1
 SWI/SNF complex,1
 Chinese,1
Congenital diaphragmatic hernia,1
 Sirolimus,1
 Spine metastasis,1
 Squamous cell lung cancer,1
 Thoracic malignancy,1
 MTT assay,1
 Cytokine,1
 miR-30a-5p,1
 Programmed cell death receptor-1 antibody,1
 therapeutic target,1
 macrophages,1
